| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Head and Neck Neoplasms | 57 | 2021 | 2515 | 7.300 |
Why?
|
| Mouth Neoplasms | 17 | 2020 | 597 | 5.060 |
Why?
|
| Carcinoma, Squamous Cell | 35 | 2021 | 3911 | 3.860 |
Why?
|
| Tongue Neoplasms | 6 | 2020 | 179 | 3.000 |
Why?
|
| Lingual Nerve | 3 | 2019 | 32 | 2.110 |
Why?
|
| Oropharyngeal Neoplasms | 7 | 2021 | 392 | 2.020 |
Why?
|
| Salivary Gland Neoplasms | 3 | 2020 | 242 | 1.950 |
Why?
|
| Otolaryngology | 10 | 2020 | 592 | 1.930 |
Why?
|
| Otorhinolaryngologic Surgical Procedures | 6 | 2020 | 316 | 1.740 |
Why?
|
| Papillomavirus Infections | 8 | 2021 | 1277 | 1.670 |
Why?
|
| Surgical Flaps | 15 | 2019 | 1608 | 1.580 |
Why?
|
| Reconstructive Surgical Procedures | 11 | 2020 | 1997 | 1.330 |
Why?
|
| Tongue | 6 | 2019 | 401 | 1.310 |
Why?
|
| Hypoglossal Nerve | 2 | 2016 | 86 | 1.200 |
Why?
|
| Tracheal Stenosis | 2 | 2017 | 207 | 1.120 |
Why?
|
| Neck Dissection | 4 | 2019 | 204 | 0.980 |
Why?
|
| Mouth | 3 | 2018 | 364 | 0.980 |
Why?
|
| Laryngeal Neoplasms | 4 | 2018 | 529 | 0.930 |
Why?
|
| African Americans | 7 | 2019 | 4975 | 0.910 |
Why?
|
| Papillomaviridae | 3 | 2018 | 1019 | 0.900 |
Why?
|
| Larynx, Artificial | 2 | 2020 | 68 | 0.890 |
Why?
|
| Cross Infection | 2 | 2020 | 1384 | 0.880 |
Why?
|
| Glossectomy | 3 | 2017 | 47 | 0.880 |
Why?
|
| Laryngoplasty | 1 | 2020 | 45 | 0.870 |
Why?
|
| Marital Status | 2 | 2019 | 435 | 0.830 |
Why?
|
| Ranula | 1 | 2019 | 12 | 0.810 |
Why?
|
| Tracheostomy | 2 | 2020 | 371 | 0.810 |
Why?
|
| Survivors | 4 | 2018 | 1913 | 0.790 |
Why?
|
| Salivary Glands | 1 | 2020 | 208 | 0.790 |
Why?
|
| Sexual Behavior | 3 | 2019 | 1785 | 0.780 |
Why?
|
| Marketing of Health Services | 1 | 2020 | 156 | 0.770 |
Why?
|
| Scalp | 4 | 2016 | 324 | 0.740 |
Why?
|
| Reimbursement, Incentive | 3 | 2020 | 527 | 0.730 |
Why?
|
| Oral Surgical Procedures | 1 | 2019 | 154 | 0.690 |
Why?
|
| Medicare | 6 | 2020 | 4760 | 0.690 |
Why?
|
| Neoplasm Staging | 11 | 2020 | 11045 | 0.690 |
Why?
|
| Cost Control | 1 | 2020 | 645 | 0.690 |
Why?
|
| Patient Advocacy | 1 | 2019 | 355 | 0.680 |
Why?
|
| Tracheotomy | 1 | 2018 | 176 | 0.680 |
Why?
|
| Infectious Disease Transmission, Patient-to-Professional | 1 | 2020 | 253 | 0.680 |
Why?
|
| State Government | 1 | 2020 | 375 | 0.670 |
Why?
|
| Insurance Coverage | 5 | 2020 | 1739 | 0.670 |
Why?
|
| Papillomavirus Vaccines | 3 | 2018 | 432 | 0.660 |
Why?
|
| Humans | 154 | 2021 | 660731 | 0.660 |
Why?
|
| Access to Information | 1 | 2020 | 309 | 0.650 |
Why?
|
| Neoplasms, Multiple Primary | 2 | 2018 | 651 | 0.630 |
Why?
|
| Free Tissue Flaps | 2 | 2017 | 247 | 0.630 |
Why?
|
| Mouth Mucosa | 2 | 2018 | 430 | 0.620 |
Why?
|
| Oropharynx | 1 | 2016 | 125 | 0.610 |
Why?
|
| Orbit | 3 | 2006 | 434 | 0.610 |
Why?
|
| Deglutition Disorders | 3 | 2018 | 541 | 0.600 |
Why?
|
| SEER Program | 9 | 2020 | 1579 | 0.600 |
Why?
|
| Cytodiagnosis | 1 | 2019 | 402 | 0.600 |
Why?
|
| Temporal Bone | 5 | 2008 | 627 | 0.590 |
Why?
|
| Colorectal Neoplasms, Hereditary Nonpolyposis | 1 | 2018 | 351 | 0.580 |
Why?
|
| Mandible | 2 | 2014 | 712 | 0.550 |
Why?
|
| Biopsy, Fine-Needle | 1 | 2019 | 984 | 0.540 |
Why?
|
| Health Status Disparities | 2 | 2015 | 1655 | 0.540 |
Why?
|
| Conflict of Interest | 1 | 2019 | 604 | 0.540 |
Why?
|
| Alphapapillomavirus | 1 | 2015 | 125 | 0.530 |
Why?
|
| Ambulatory Care Facilities | 1 | 2020 | 799 | 0.530 |
Why?
|
| Middle Aged | 75 | 2020 | 210747 | 0.530 |
Why?
|
| Myoblasts | 2 | 2006 | 259 | 0.520 |
Why?
|
| European Continental Ancestry Group | 6 | 2019 | 7199 | 0.520 |
Why?
|
| Thyroid Cartilage | 4 | 2004 | 38 | 0.510 |
Why?
|
| Surgery, Computer-Assisted | 1 | 2021 | 1012 | 0.510 |
Why?
|
| Aged | 61 | 2020 | 156937 | 0.500 |
Why?
|
| Coronavirus Infections | 3 | 2020 | 3235 | 0.500 |
Why?
|
| Pneumonia, Viral | 3 | 2020 | 3350 | 0.500 |
Why?
|
| Cross-Sectional Studies | 12 | 2020 | 20390 | 0.500 |
Why?
|
| Male | 87 | 2020 | 343917 | 0.490 |
Why?
|
| Retrospective Studies | 40 | 2021 | 63232 | 0.490 |
Why?
|
| Cause of Death | 3 | 2018 | 3464 | 0.480 |
Why?
|
| Pandemics | 3 | 2020 | 5107 | 0.480 |
Why?
|
| Laryngectomy | 5 | 2020 | 230 | 0.470 |
Why?
|
| Ophthalmologic Surgical Procedures | 2 | 2006 | 328 | 0.470 |
Why?
|
| Microsurgery | 3 | 2009 | 771 | 0.470 |
Why?
|
| Medicaid | 4 | 2020 | 2388 | 0.470 |
Why?
|
| United States | 30 | 2020 | 63218 | 0.460 |
Why?
|
| Craniotomy | 1 | 2016 | 692 | 0.460 |
Why?
|
| Female | 84 | 2020 | 365199 | 0.460 |
Why?
|
| Drug Industry | 1 | 2019 | 898 | 0.460 |
Why?
|
| Anemia | 2 | 2019 | 1336 | 0.460 |
Why?
|
| Ear Neoplasms | 3 | 2008 | 114 | 0.450 |
Why?
|
| Skull | 1 | 2016 | 782 | 0.450 |
Why?
|
| Life Expectancy | 1 | 2017 | 1120 | 0.430 |
Why?
|
| Ultrasonography | 3 | 2020 | 5774 | 0.430 |
Why?
|
| Awareness | 1 | 2015 | 608 | 0.430 |
Why?
|
| Neoplasms, Second Primary | 2 | 2018 | 954 | 0.430 |
Why?
|
| Quality of Life | 7 | 2018 | 10147 | 0.420 |
Why?
|
| Frozen Sections | 3 | 2020 | 168 | 0.420 |
Why?
|
| Nose Neoplasms | 3 | 2016 | 237 | 0.420 |
Why?
|
| Skull Base Neoplasms | 3 | 2008 | 237 | 0.420 |
Why?
|
| Trachea | 2 | 2015 | 1102 | 0.410 |
Why?
|
| Survival Analysis | 8 | 2018 | 10602 | 0.400 |
Why?
|
| Lip | 2 | 2009 | 192 | 0.400 |
Why?
|
| Salvage Therapy | 3 | 2018 | 1274 | 0.390 |
Why?
|
| Postoperative Complications | 8 | 2020 | 14748 | 0.390 |
Why?
|
| Inpatients | 1 | 2019 | 1946 | 0.380 |
Why?
|
| Surgical Wound Infection | 1 | 2018 | 1399 | 0.370 |
Why?
|
| Disease-Free Survival | 8 | 2019 | 7080 | 0.370 |
Why?
|
| Neoplasm Recurrence, Local | 9 | 2021 | 8158 | 0.370 |
Why?
|
| Preoperative Care | 1 | 2018 | 2390 | 0.360 |
Why?
|
| Adult | 52 | 2020 | 206295 | 0.360 |
Why?
|
| Drug Prescriptions | 1 | 2018 | 1603 | 0.360 |
Why?
|
| Otorhinolaryngologic Diseases | 1 | 2008 | 96 | 0.350 |
Why?
|
| Societies, Medical | 1 | 2019 | 3597 | 0.340 |
Why?
|
| Health Knowledge, Attitudes, Practice | 4 | 2017 | 3963 | 0.340 |
Why?
|
| Thyroid Neoplasms | 2 | 2018 | 1997 | 0.340 |
Why?
|
| Laryngostenosis | 2 | 2010 | 155 | 0.330 |
Why?
|
| Analgesics, Opioid | 2 | 2020 | 2797 | 0.320 |
Why?
|
| Deglutition | 2 | 2019 | 191 | 0.320 |
Why?
|
| Bone Marrow Cells | 1 | 2014 | 2705 | 0.310 |
Why?
|
| Patient Protection and Affordable Care Act | 3 | 2020 | 1137 | 0.310 |
Why?
|
| Stents | 2 | 2017 | 3216 | 0.310 |
Why?
|
| Aged, 80 and over | 25 | 2020 | 57680 | 0.280 |
Why?
|
| Orbit Evisceration | 1 | 2003 | 11 | 0.280 |
Why?
|
| Orbital Diseases | 1 | 2006 | 212 | 0.280 |
Why?
|
| Microcirculation | 1 | 2009 | 1281 | 0.280 |
Why?
|
| Intensive Care Units | 1 | 2017 | 3090 | 0.270 |
Why?
|
| Alcohol Drinking | 1 | 2017 | 3811 | 0.270 |
Why?
|
| Radiotherapy, Adjuvant | 6 | 2020 | 1880 | 0.270 |
Why?
|
| Sex Factors | 6 | 2019 | 10678 | 0.270 |
Why?
|
| Neoplasms | 4 | 2019 | 18476 | 0.270 |
Why?
|
| Coloring Agents | 2 | 2021 | 551 | 0.270 |
Why?
|
| Carcinoma, Basal Cell | 5 | 2008 | 493 | 0.270 |
Why?
|
| Prognosis | 9 | 2019 | 28027 | 0.260 |
Why?
|
| Reimbursement Mechanisms | 2 | 2020 | 654 | 0.260 |
Why?
|
| Rectus Abdominis | 1 | 2003 | 102 | 0.260 |
Why?
|
| Depressive Disorder, Major | 2 | 2019 | 4111 | 0.260 |
Why?
|
| Treatment Outcome | 16 | 2019 | 59149 | 0.260 |
Why?
|
| Jugular Veins | 1 | 2004 | 221 | 0.250 |
Why?
|
| Receptors, Antigen, T-Cell, gamma-delta | 3 | 2013 | 333 | 0.250 |
Why?
|
| Laryngeal Diseases | 2 | 2020 | 240 | 0.250 |
Why?
|
| Skin Neoplasms | 4 | 2016 | 5202 | 0.250 |
Why?
|
| Fistula | 3 | 2012 | 207 | 0.250 |
Why?
|
| Phonation | 2 | 2020 | 209 | 0.250 |
Why?
|
| Delivery of Health Care | 1 | 2020 | 4256 | 0.240 |
Why?
|
| Communication | 1 | 2016 | 3118 | 0.240 |
Why?
|
| Bone Neoplasms | 1 | 2014 | 2516 | 0.240 |
Why?
|
| Forearm | 4 | 2016 | 419 | 0.240 |
Why?
|
| Fascia | 2 | 2000 | 132 | 0.240 |
Why?
|
| Neoplasm Invasiveness | 6 | 2020 | 3756 | 0.240 |
Why?
|
| Facial Neoplasms | 2 | 2002 | 134 | 0.230 |
Why?
|
| Reoperation | 4 | 2018 | 4123 | 0.230 |
Why?
|
| Adenocarcinoma | 3 | 2018 | 6377 | 0.230 |
Why?
|
| Rats, Wistar | 2 | 2016 | 2074 | 0.230 |
Why?
|
| Eye Diseases | 1 | 2006 | 668 | 0.220 |
Why?
|
| Cricoid Cartilage | 2 | 2015 | 70 | 0.220 |
Why?
|
| Endocrine Surgical Procedures | 1 | 2020 | 26 | 0.220 |
Why?
|
| Pharyngectomy | 1 | 2000 | 45 | 0.220 |
Why?
|
| Parotid Neoplasms | 2 | 2019 | 168 | 0.220 |
Why?
|
| Socioeconomic Factors | 4 | 2019 | 7782 | 0.220 |
Why?
|
| Relative Value Scales | 1 | 2020 | 87 | 0.210 |
Why?
|
| Prostheses and Implants | 3 | 2000 | 1287 | 0.210 |
Why?
|
| Fee Schedules | 1 | 2020 | 87 | 0.210 |
Why?
|
| CD8-Positive T-Lymphocytes | 4 | 2015 | 3852 | 0.210 |
Why?
|
| Smoking | 2 | 2017 | 8930 | 0.210 |
Why?
|
| Postoperative Care | 3 | 2020 | 1557 | 0.210 |
Why?
|
| Intubation | 1 | 2000 | 144 | 0.210 |
Why?
|
| Logistic Models | 5 | 2020 | 13647 | 0.210 |
Why?
|
| Epistaxis | 1 | 2000 | 102 | 0.210 |
Why?
|
| Positron-Emission Tomography | 2 | 2013 | 5727 | 0.200 |
Why?
|
| Nose | 2 | 2020 | 469 | 0.200 |
Why?
|
| Adenoviruses, Human | 2 | 2014 | 307 | 0.200 |
Why?
|
| Sphenoid Bone | 1 | 2000 | 164 | 0.200 |
Why?
|
| Toll-Like Receptor 8 | 3 | 2014 | 88 | 0.200 |
Why?
|
| Neoplasm Metastasis | 4 | 2019 | 5294 | 0.200 |
Why?
|
| Skull Neoplasms | 2 | 2007 | 190 | 0.200 |
Why?
|
| Illinois | 1 | 2019 | 107 | 0.200 |
Why?
|
| Prospective Payment System | 1 | 2020 | 132 | 0.190 |
Why?
|
| Mandibular Neoplasms | 1 | 2000 | 137 | 0.190 |
Why?
|
| Carcinoma, Mucoepidermoid | 1 | 2019 | 83 | 0.190 |
Why?
|
| Insurance, Health | 4 | 2020 | 2398 | 0.190 |
Why?
|
| Lymphocytes, Tumor-Infiltrating | 2 | 2015 | 951 | 0.190 |
Why?
|
| 4-Nitroquinoline-1-oxide | 1 | 2017 | 12 | 0.190 |
Why?
|
| Dissection | 2 | 2019 | 273 | 0.190 |
Why?
|
| Momordica charantia | 1 | 2017 | 6 | 0.190 |
Why?
|
| Immune System Phenomena | 1 | 2017 | 18 | 0.190 |
Why?
|
| Managed Competition | 1 | 2018 | 36 | 0.190 |
Why?
|
| Carotid Artery, Common | 2 | 2009 | 191 | 0.180 |
Why?
|
| Vocal Cord Paralysis | 3 | 2000 | 234 | 0.180 |
Why?
|
| Multivariate Analysis | 3 | 2018 | 12724 | 0.180 |
Why?
|
| Suicide | 2 | 2018 | 1402 | 0.180 |
Why?
|
| Carotid Artery, Internal | 1 | 2000 | 426 | 0.180 |
Why?
|
| Hematocrit | 1 | 2019 | 640 | 0.180 |
Why?
|
| Surgical Wound Dehiscence | 1 | 2019 | 219 | 0.180 |
Why?
|
| Mi-2 Nucleosome Remodeling and Deacetylase Complex | 1 | 2018 | 103 | 0.180 |
Why?
|
| Carcinoma, Adenoid Cystic | 4 | 2008 | 248 | 0.180 |
Why?
|
| Aerosols | 1 | 2020 | 674 | 0.170 |
Why?
|
| Models, Educational | 1 | 2020 | 403 | 0.170 |
Why?
|
| Outpatient Clinics, Hospital | 1 | 2020 | 431 | 0.170 |
Why?
|
| CD4-Positive T-Lymphocytes | 4 | 2015 | 4258 | 0.170 |
Why?
|
| Cohort Studies | 8 | 2020 | 37121 | 0.170 |
Why?
|
| Vaccination | 2 | 2018 | 2192 | 0.170 |
Why?
|
| Esophagectomy | 1 | 2000 | 399 | 0.170 |
Why?
|
| Skin Transplantation | 2 | 2000 | 1259 | 0.170 |
Why?
|
| Dentigerous Cyst | 1 | 1996 | 20 | 0.170 |
Why?
|
| Immunization Schedule | 1 | 2018 | 221 | 0.170 |
Why?
|
| Adenoidectomy | 1 | 2018 | 170 | 0.170 |
Why?
|
| Medically Uninsured | 2 | 2020 | 835 | 0.170 |
Why?
|
| Cutaneous Fistula | 2 | 2012 | 84 | 0.170 |
Why?
|
| Regression Analysis | 3 | 2017 | 6691 | 0.170 |
Why?
|
| Preoperative Period | 1 | 2019 | 534 | 0.170 |
Why?
|
| Maxillary Diseases | 1 | 1996 | 51 | 0.170 |
Why?
|
| Face | 2 | 2002 | 951 | 0.160 |
Why?
|
| Regeneration | 1 | 2006 | 1537 | 0.160 |
Why?
|
| Plant Extracts | 2 | 2017 | 445 | 0.160 |
Why?
|
| Intraoperative Period | 1 | 2017 | 561 | 0.160 |
Why?
|
| Liver Function Tests | 1 | 2018 | 539 | 0.160 |
Why?
|
| Speech | 1 | 2020 | 472 | 0.160 |
Why?
|
| Physician Incentive Plans | 1 | 2018 | 177 | 0.160 |
Why?
|
| Reference Standards | 1 | 2019 | 845 | 0.160 |
Why?
|
| Risk Assessment | 5 | 2020 | 22923 | 0.160 |
Why?
|
| Facial Nerve | 1 | 1999 | 269 | 0.160 |
Why?
|
| Young Adult | 12 | 2020 | 54078 | 0.160 |
Why?
|
| Granuloma, Laryngeal | 1 | 1995 | 8 | 0.160 |
Why?
|
| Paranasal Sinus Neoplasms | 3 | 2016 | 219 | 0.160 |
Why?
|
| Fluorodeoxyglucose F18 | 3 | 2013 | 1929 | 0.160 |
Why?
|
| Odds Ratio | 3 | 2019 | 9927 | 0.160 |
Why?
|
| Adolescent | 19 | 2020 | 82796 | 0.160 |
Why?
|
| Tonsillar Neoplasms | 1 | 1996 | 58 | 0.160 |
Why?
|
| Tonsillectomy | 1 | 2018 | 262 | 0.150 |
Why?
|
| Age Factors | 4 | 2018 | 19040 | 0.150 |
Why?
|
| Blood Chemical Analysis | 1 | 2018 | 470 | 0.150 |
Why?
|
| Mastication | 1 | 2015 | 66 | 0.150 |
Why?
|
| Neck Muscles | 1 | 2015 | 104 | 0.150 |
Why?
|
| Kidney Function Tests | 1 | 2018 | 705 | 0.150 |
Why?
|
| Granuloma, Foreign-Body | 1 | 1995 | 44 | 0.150 |
Why?
|
| Thigh | 1 | 2016 | 228 | 0.150 |
Why?
|
| Databases, Factual | 5 | 2019 | 7515 | 0.150 |
Why?
|
| Consensus Development Conferences as Topic | 1 | 2015 | 173 | 0.150 |
Why?
|
| Paranasal Sinus Diseases | 2 | 2012 | 128 | 0.150 |
Why?
|
| T-Lymphocytes, Regulatory | 3 | 2013 | 2847 | 0.150 |
Why?
|
| Wrist | 1 | 1996 | 202 | 0.150 |
Why?
|
| Tumor Microenvironment | 5 | 2017 | 2033 | 0.150 |
Why?
|
| Laryngeal Nerves | 1 | 1994 | 55 | 0.140 |
Why?
|
| Rats, Inbred Lew | 3 | 2006 | 1199 | 0.140 |
Why?
|
| Rats | 5 | 2016 | 25424 | 0.140 |
Why?
|
| Disease Transmission, Infectious | 1 | 2020 | 547 | 0.140 |
Why?
|
| Pharyngeal Muscles | 1 | 1994 | 76 | 0.140 |
Why?
|
| Polytetrafluoroethylene | 1 | 1995 | 250 | 0.140 |
Why?
|
| Cucurbitaceae | 1 | 2013 | 4 | 0.140 |
Why?
|
| Sexual Partners | 1 | 2019 | 679 | 0.140 |
Why?
|
| Office Visits | 1 | 2019 | 592 | 0.140 |
Why?
|
| Spiral Ganglion | 1 | 2015 | 160 | 0.140 |
Why?
|
| Tomography, X-Ray Computed | 5 | 2013 | 20102 | 0.140 |
Why?
|
| Survival Rate | 8 | 2019 | 13249 | 0.140 |
Why?
|
| Carotid Artery Diseases | 1 | 2000 | 876 | 0.140 |
Why?
|
| Independent Living | 1 | 2017 | 426 | 0.140 |
Why?
|
| Betapapillomavirus | 1 | 2013 | 6 | 0.140 |
Why?
|
| Proportional Hazards Models | 3 | 2019 | 12179 | 0.130 |
Why?
|
| Neoplasms, Radiation-Induced | 1 | 2018 | 601 | 0.130 |
Why?
|
| Hand Strength | 1 | 1996 | 417 | 0.130 |
Why?
|
| Hospitals, University | 1 | 2015 | 599 | 0.130 |
Why?
|
| Paralysis | 1 | 1994 | 226 | 0.130 |
Why?
|
| Adenovirus E1A Proteins | 1 | 2013 | 94 | 0.130 |
Why?
|
| Incidence | 4 | 2019 | 19739 | 0.130 |
Why?
|
| Prosthesis Design | 1 | 2020 | 2201 | 0.130 |
Why?
|
| Cannabis | 1 | 2016 | 216 | 0.130 |
Why?
|
| Prevalence | 3 | 2019 | 14259 | 0.130 |
Why?
|
| Internationality | 1 | 2019 | 984 | 0.130 |
Why?
|
| Lymphoma | 1 | 2002 | 1855 | 0.130 |
Why?
|
| Chondroblastoma | 1 | 1992 | 52 | 0.120 |
Why?
|
| Vascular Surgical Procedures | 1 | 2002 | 1504 | 0.120 |
Why?
|
| Fellowships and Scholarships | 1 | 2020 | 880 | 0.120 |
Why?
|
| Delayed Diagnosis | 1 | 2015 | 389 | 0.120 |
Why?
|
| Down-Regulation | 3 | 2018 | 3212 | 0.120 |
Why?
|
| Bone Resorption | 1 | 1996 | 745 | 0.120 |
Why?
|
| Risk-Taking | 1 | 2018 | 1017 | 0.120 |
Why?
|
| Cranial Irradiation | 1 | 2015 | 433 | 0.120 |
Why?
|
| Predictive Value of Tests | 2 | 2019 | 15038 | 0.120 |
Why?
|
| Oncolytic Virotherapy | 2 | 2014 | 425 | 0.120 |
Why?
|
| Nasal Cavity | 3 | 2019 | 293 | 0.120 |
Why?
|
| Healthcare Disparities | 2 | 2018 | 2820 | 0.120 |
Why?
|
| Oncogene Proteins, Viral | 1 | 2013 | 391 | 0.110 |
Why?
|
| Lymphatic Metastasis | 1 | 2019 | 3030 | 0.110 |
Why?
|
| Incidental Findings | 3 | 2011 | 685 | 0.110 |
Why?
|
| Intracranial Aneurysm | 1 | 2000 | 1143 | 0.110 |
Why?
|
| Motivation | 1 | 2020 | 1798 | 0.110 |
Why?
|
| Neurosurgical Procedures | 1 | 2002 | 1835 | 0.110 |
Why?
|
| African Continental Ancestry Group | 1 | 2019 | 1984 | 0.110 |
Why?
|
| Coculture Techniques | 4 | 2018 | 1377 | 0.110 |
Why?
|
| Hospitalization | 2 | 2020 | 8701 | 0.110 |
Why?
|
| Pain, Postoperative | 1 | 2020 | 1406 | 0.110 |
Why?
|
| Registries | 3 | 2020 | 7622 | 0.100 |
Why?
|
| Tissue Engineering | 3 | 2006 | 1850 | 0.100 |
Why?
|
| Cochlea | 1 | 2015 | 721 | 0.100 |
Why?
|
| Antineoplastic Agents, Phytogenic | 1 | 2013 | 651 | 0.100 |
Why?
|
| Animals | 18 | 2020 | 168501 | 0.100 |
Why?
|
| Mice, SCID | 4 | 2017 | 2834 | 0.100 |
Why?
|
| Proto-Oncogene Proteins c-met | 1 | 2013 | 585 | 0.100 |
Why?
|
| Biopsy | 3 | 2018 | 6699 | 0.100 |
Why?
|
| Health Expenditures | 2 | 2019 | 2087 | 0.100 |
Why?
|
| Cadaver | 3 | 2020 | 1263 | 0.100 |
Why?
|
| Risk Factors | 10 | 2020 | 66887 | 0.100 |
Why?
|
| Missouri | 1 | 2008 | 111 | 0.090 |
Why?
|
| Disease Models, Animal | 3 | 2017 | 18133 | 0.090 |
Why?
|
| Pneumonia | 1 | 2019 | 1918 | 0.090 |
Why?
|
| Chemotherapy, Adjuvant | 4 | 2020 | 3385 | 0.090 |
Why?
|
| Ear Auricle | 1 | 2008 | 38 | 0.090 |
Why?
|
| Cell Line, Tumor | 8 | 2020 | 16539 | 0.090 |
Why?
|
| Subclavian Artery | 1 | 2008 | 136 | 0.090 |
Why?
|
| Hodgkin Disease | 1 | 1996 | 1414 | 0.090 |
Why?
|
| Feasibility Studies | 1 | 2017 | 4652 | 0.090 |
Why?
|
| Pilot Projects | 2 | 2020 | 7624 | 0.090 |
Why?
|
| Activities of Daily Living | 1 | 2017 | 2201 | 0.090 |
Why?
|
| Risk | 2 | 2020 | 9826 | 0.090 |
Why?
|
| Case-Control Studies | 4 | 2020 | 21201 | 0.090 |
Why?
|
| Adaptive Immunity | 1 | 2013 | 683 | 0.090 |
Why?
|
| T-Lymphocyte Subsets | 2 | 2015 | 1881 | 0.090 |
Why?
|
| Maxillary Sinus | 2 | 2000 | 134 | 0.090 |
Why?
|
| Neck | 3 | 2005 | 673 | 0.090 |
Why?
|
| Breast Neoplasms | 4 | 2015 | 18853 | 0.080 |
Why?
|
| Follow-Up Studies | 8 | 2019 | 38875 | 0.080 |
Why?
|
| Neoplastic Stem Cells | 1 | 2015 | 1353 | 0.080 |
Why?
|
| Multiprotein Complexes | 1 | 2013 | 1157 | 0.080 |
Why?
|
| Nursing Staff, Hospital | 1 | 2009 | 337 | 0.080 |
Why?
|
| Carbon | 2 | 2006 | 638 | 0.080 |
Why?
|
| Lymphoma, T-Cell | 1 | 2008 | 308 | 0.080 |
Why?
|
| Combined Modality Therapy | 3 | 2013 | 9035 | 0.080 |
Why?
|
| Head | 2 | 2005 | 753 | 0.070 |
Why?
|
| Mice, Inbred NOD | 3 | 2015 | 1912 | 0.070 |
Why?
|
| Treatment Failure | 1 | 2011 | 2647 | 0.070 |
Why?
|
| Quality Improvement | 1 | 2020 | 3473 | 0.070 |
Why?
|
| Ear, External | 3 | 2007 | 160 | 0.070 |
Why?
|
| Critical Care | 1 | 2017 | 2284 | 0.070 |
Why?
|
| Biomedical Research | 1 | 2020 | 3159 | 0.070 |
Why?
|
| MAP Kinase Signaling System | 1 | 2012 | 1600 | 0.070 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2018 | 2861 | 0.070 |
Why?
|
| Radiotherapy Dosage | 3 | 2018 | 2911 | 0.070 |
Why?
|
| Physicians | 1 | 2020 | 3907 | 0.070 |
Why?
|
| Parotid Gland | 2 | 2007 | 160 | 0.070 |
Why?
|
| Immunity, Innate | 2 | 2013 | 2833 | 0.070 |
Why?
|
| Epithelial-Mesenchymal Transition | 2 | 2019 | 666 | 0.070 |
Why?
|
| Hematoma | 2 | 2005 | 682 | 0.060 |
Why?
|
| Health Services Accessibility | 1 | 2019 | 4773 | 0.060 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2009 | 1369 | 0.060 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2013 | 3020 | 0.060 |
Why?
|
| Early Detection of Cancer | 1 | 2015 | 2474 | 0.060 |
Why?
|
| Mice | 10 | 2020 | 79108 | 0.060 |
Why?
|
| Child | 6 | 2017 | 68786 | 0.060 |
|